A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers
Part of paid clinical trials in Glendale, California.
- Sponsor
- AstraZeneca
- Study ID
- NCT06951880
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- AZD4916 — DRUGAZD4916 will be administered as oral solution.
- Placebo — OTHERPlacebo will be administered as oral solution.
Study Details
The main purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) of AZD4916 in healthy adult participants.
Key Dates
- Start date
- Jul 23, 2026
- Status verified
- May 2026
- Primary completion
- Oct 25, 2027
- Completion
- Oct 25, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: AZD4916Parts 1a and 2a participants will receive a single oral dose of AZD4916 on Day 1. Parts 1b and 2b participants will receive a single oral dose of AZD4916 on Day 1 and multiple doses of AZD4916 on Days 4 through 17.
- Placebo Comparator: PlaceboParts 1a and 2a participants will receive a single oral dose of placebo on Day 1. Parts 1b and 2b participants will receive a single dose placebo on Day 1 and multiple doses of placebo on Days 4 through 17.
Primary Outcome Measure
Number of participants with adverse events (AEs) [ Time Frame: From Screening (Day -29 to Day -2) up to 44 days ]
Central Contacts
- AstraZeneca Clinical Study Information Center1-877-240-9479
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Glendale | California | 91206 | - |
Find similar trials in Glendale, CA
By research site
Related Studies
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)PHASE1 · Recruiting · Equilibra Bioscience LLC · Glendale, California
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaPHASE1 · Recruiting · AstraZeneca · Glendale, California
- A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityPHASE1 · Recruiting · AstraZeneca · Glendale, California